National Bank of Canada FI Has $13.87 Million Holdings in The Clorox Company (NYSE:CLX)

Key Points

• National Bank of Canada FI increased its holdings in The Clorox Company by 60.4%, owning approximately $13.87 million worth of stock after purchasing 35,462 additional shares.
• Clorox reported a quarterly EPS of $2.87, exceeding analysts' expectations of $2.24, and showing a 4.5% revenue increase year-over-year.
• The company announced a quarterly dividend increase to $1.24 per share, reflecting a 4.1% dividend yield and a payout ratio of 74.85%.

National Bank of Canada FI increased its stake in The Clorox Company (NYSE:CLX - Free Report) by 60.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 94,157 shares of the company's stock after buying an additional 35,462 shares during the quarter. National Bank of Canada FI owned approximately 0.08% of Clorox worth $13,865,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CLX. Wood Tarver Financial Group LLC acquired a new stake in shares of Clorox in the 4th quarter valued at approximately $31,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Clorox in the 4th quarter valued at approximately $32,000. GW&K Investment Management LLC boosted its holdings in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after buying an additional 208 shares during the last quarter. Roble Belko & Company Inc raised its stake in Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the period. Finally, IMA Advisory Services Inc. bought a new stake in Clorox in the 1st quarter valued at $58,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Stock Down 2.2%

Shares of NYSE CLX opened at $122.15 on Tuesday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 52 week low of $117.35 and a 52 week high of $171.37. The stock has a market capitalization of $15.05 billion, a P/E ratio of 18.73, a PEG ratio of 1.00 and a beta of 0.49. The stock's fifty day moving average is $125.35 and its 200 day moving average is $137.38.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%. The company had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. During the same quarter last year, the business earned $1.82 earnings per share. Clorox's revenue was up 4.5% on a year-over-year basis. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be given a $1.24 dividend. The ex-dividend date is Wednesday, August 13th. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. Clorox's dividend payout ratio (DPR) is 74.85%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CLX. Barclays dropped their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a research note on Tuesday, May 6th. Jefferies Financial Group dropped their price target on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Citigroup restated a "neutral" rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Finally, Wells Fargo & Company increased their price target on Clorox from $135.00 to $138.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $143.36.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.